Last $1.66 USD
Change Today +0.02 / 1.22%
Volume 921.1K
GALE On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 01/23/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark W. Schwartz Ph.D.

Chief Executive Officer, President and Director, Galena Biopharma, Inc.
AgeTotal Calculated CompensationThis person is connected to 27 board members in 3 different organizations across 4 different industries.

See Board Relationships
59$1,584,333
As of Fiscal Year 2013

Background*

Dr. Mark W. Schwartz, Ph.D. has been the Chief Executive Officer and President of Galena Biopharma, Inc. since August 2014. Dr. Schwartz served as the Chief Operating Officer and Executive Vice President at Galena Biopharma, Inc. until August 2014. Dr. Schwartz served as the Chief Executive Officer and President at Apthera Inc. since January 2010. Dr. Schwartz served as the Chief Executive Officer and President of Bayhill Therapeutics Inc. from March 2004 to September ...

Read Full Background

Corporate Headquarters*

4640 SW Macadam Avenue
Portland, Oregon 97239

United States

Phone: 855-855-4253
Fax: --

Board Members Memberships*

Chief Executive Officer, President and Director
2004-N/A
Former Chief Executive Officer and President
2010-Present
Chief Executive Officer, President and Director
2014-Present
Director

Education*

PhD
Arizona State University-Tempe
BA
Grinnell College

Other Affiliations*

Annual Compensation*

Salary$365,000
Bonus$125,000
Total Annual Compensation$490,000

Stock Options*

All Other Compensation$693
Exercisable Options417,695
Unexercisable Options622,305
Total Number of Options1,040,000

Total Compensation*

Total Annual Cash Compensation$490,693
Total Short Term Compensation$490,000
Other Long Term Compensation$693
Total Calculated Compensation$1,584,333
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GALE:US $1.66 USD +0.02

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ali Mortazavi Chief Executive and Director
Silence Therapeutics plc
70.0K GBP
Mark A. Sirgo Pharm.D.Chief Executive Officer, President, Chief Scientific Officer, Executive Director and Member of Executive Subcommittee
BioDelivery Sciences International, Inc.
$739.3K
Peter French B.Sc, M.Sc, Ph.D., MBAChief Executive Officer, Managing Director and Director
Benitec Biopharma Limited
A$450.0K
Hans G. C. P. Schikan Chief Executive Officer and Member of Management Board
Prosensa Holding N.V.
--
Mark J. Murray Ph.D.Chief Executive Officer, President and Director
Tekmira Pharmaceuticals Corporation
$377.5K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GALENA BIOPHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.